These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. G protein activation in rat ponto-mesencephalic nuclei is enhanced by combined treatment with a mu opioid and an adenosine A1 receptor agonist. Tanase D; Martin WA; Baghdoyan HA; Lydic R Sleep; 2001 Feb; 24(1):52-62. PubMed ID: 11204054 [TBL] [Abstract][Full Text] [Related]
25. Estrogen modulation of mu-opioid receptor-stimulated [35S]-GTP-gamma-S binding in female rat brain visualized by in vitro autoradiography. Acosta-Martinez M; Etgen AM Neuroendocrinology; 2002 Oct; 76(4):235-42. PubMed ID: 12411740 [TBL] [Abstract][Full Text] [Related]
26. Opioid receptor-coupled G-proteins in rat locus coeruleus membranes: decrease in activity after chronic morphine treatment. Selley DE; Nestler EJ; Breivogel CS; Childers SR Brain Res; 1997 Jan; 746(1-2):10-8. PubMed ID: 9037478 [TBL] [Abstract][Full Text] [Related]
27. Lack of evidence of kappa2-selective activation of G-proteins: kappa opioid receptor stimulation of [35S] GTPgammaS binding in guinea pig brain. Childers SR; Xiao R; Vogt L; Sim LJ Biochem Pharmacol; 1998 Jul; 56(1):113-20. PubMed ID: 9698095 [TBL] [Abstract][Full Text] [Related]
28. Opioid peptide receptor studies. 17. Attenuation of chronic morphine effects after antisense oligodeoxynucleotide knock-down of RGS9 protein in cells expressing the cloned Mu opioid receptor. Xu H; Wang X; Wang J; Rothman RB Synapse; 2004 Jun; 52(3):209-17. PubMed ID: 15065220 [TBL] [Abstract][Full Text] [Related]
29. Functional and anatomical localization of mu opioid receptors in the striatum, amygdala, and extended amygdala of the nonhuman primate. Daunais JB; Letchworth SR; Sim-Selley LJ; Smith HR; Childers SR; Porrino LJ J Comp Neurol; 2001 May; 433(4):471-85. PubMed ID: 11304712 [TBL] [Abstract][Full Text] [Related]
30. Region-dependent attenuation of mu opioid receptor-mediated G-protein activation in mouse CNS as a function of morphine tolerance. Sim-Selley LJ; Scoggins KL; Cassidy MP; Smith LA; Dewey WL; Smith FL; Selley DE Br J Pharmacol; 2007 Aug; 151(8):1324-33. PubMed ID: 17572699 [TBL] [Abstract][Full Text] [Related]
31. [(35)S]GTPγS binding and opioid tolerance and efficacy in mouse spinal cord. Madia PA; Navani DM; Yoburn BC Pharmacol Biochem Behav; 2012 Mar; 101(1):155-65. PubMed ID: 22108651 [TBL] [Abstract][Full Text] [Related]
32. Nucleoside diphosphate kinase associated with membranes modulates mu-opioid receptor-mediated [35S]GTPgammaS binding and agonist binding to mu-opioid receptor. Zhang D; Li JG; Chen C; Liu-Chen LY Eur J Pharmacol; 1999 Jul; 377(2-3):223-31. PubMed ID: 10456435 [TBL] [Abstract][Full Text] [Related]
33. Effects of chronic treatment with delta9-tetrahydrocannabinol on cannabinoid-stimulated [35S]GTPgammaS autoradiography in rat brain. Sim LJ; Hampson RE; Deadwyler SA; Childers SR J Neurosci; 1996 Dec; 16(24):8057-66. PubMed ID: 8987831 [TBL] [Abstract][Full Text] [Related]
34. Effects of continuous opioid receptor blockade on alcohol intake and up-regulation of opioid receptor subtype signalling in a genetic model of high alcohol drinking. Hyytiä P; Ingman K; Soini SL; Laitinen JT; Korpi ER Naunyn Schmiedebergs Arch Pharmacol; 1999 Oct; 360(4):391-401. PubMed ID: 10551276 [TBL] [Abstract][Full Text] [Related]
35. Mu-opioid receptor specific antagonist cyprodime: characterization by in vitro radioligand and [35S]GTPgammaS binding assays. Márki A; Monory K; Otvös F; Tóth G; Krassnig R; Schmidhammer H; Traynor JR; Roques BP; Maldonado R; Borsodi A Eur J Pharmacol; 1999 Oct; 383(2):209-14. PubMed ID: 10585536 [TBL] [Abstract][Full Text] [Related]
36. Effects of intracerebroventricular administration of beta-funaltrexamine on DAMGO-stimulated [35S]GTP-gamma-S binding in rat brain sections. Martin TJ; Sim LJ; Selley DE; deMontis MG; Childers SR Synapse; 1997 Nov; 27(3):177-82. PubMed ID: 9329153 [TBL] [Abstract][Full Text] [Related]
37. Effect of strain and sex on mu opioid receptor-mediated G-protein activation in rat brain. Selley DE; Herbert JT; Morgan D; Cook CD; Picker MJ; Sim-Selley LJ Brain Res Bull; 2003 May; 60(3):201-8. PubMed ID: 12754081 [TBL] [Abstract][Full Text] [Related]
38. Absence of G-protein activation by mu-opioid receptor agonists in the spinal cord of mu-opioid receptor knockout mice. Narita M; Mizoguchi H; Narita M; Sora I; Uhl GR; Tseng LF Br J Pharmacol; 1999 Jan; 126(2):451-6. PubMed ID: 10077238 [TBL] [Abstract][Full Text] [Related]
39. Inhibition of morphine tolerance and dependence by diazepam and its relation to mu-opioid receptors in the rat brain and spinal cord. Tejwani GA; Sheu MJ; Sribanditmongkol P; Satyapriya A Brain Res; 1998 Jun; 797(2):305-12. PubMed ID: 9666154 [TBL] [Abstract][Full Text] [Related]
40. Mu opioid receptor efficacy and potency of morphine-6-glucuronide in neonatal guinea pig brainstem membranes: comparison with transfected CHO cells. Gray RE; Munks MW; Haynes RR; Olsen GD Brain Res Bull; 2001 Mar; 54(5):499-505. PubMed ID: 11397539 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]